The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy

Tarec Christoffer El-Galaly, Diego Villa, Thomas Yssing Michaelsen, Martin Hutchings, Nabegh George Mikhaeel, Kerry J. Savage, Laurie H. Sehn, Sally Barrington, Jakob W. Hansen, Daniel Smith, Kirsty Rady, Karen J. Mylam, Thomas S. Larsen, Staffan Holmberg, Maja B. Juul, Sabrina Cordua, Michael R. Clausen, Kristina B. Jensen, Hans E. Johnsen, John F. SeymourJoseph M. Connors, Peter de Nully Brown, Martin Bøgsted, Chan Y. Cheah

Research output: Contribution to journalArticlepeer-review

74 Citations (Scopus)
205 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy'. Together they form a unique fingerprint.

Medicine and Dentistry